Chronic lymphocytic leukemia (CLL) is a B-cell malignancy characterized by a wide range of
tumor-induced alterations, which affect both the innate and adaptive arms of the immune …

Introduction: The majority of patients with CLL will suffer from infections during their disease,
accounting for approximately 60% of deaths in CLL. Patients are predisposed to infection …

We studied the risk of infections in patients with chronic lymphocytic leukemia/small
lymphocytic lymphoma (CLL). Major infections were defined as requiring hospital admission …

The complexity of the treatment of patients with chronic lymphocytic leukemia has increased
substantially over the past several years as a consequence of the advent of novel biological …

Infectious complications are a major cause of morbidity and mortality in patients with primary
or secondary immunodeficiency. Prevention of infectious diseases by vaccines is among the …

Cellular blood components and plasma-derived medicinal products (PDMPs) are obtained
from blood donated by volunteers. In a growing number of countries, in line with World …

Simple Summary In chronic lymphocytic leukemia (CLL), immune alterations—affecting both
the innate and adaptive immunity—are very common. As a clinical consequence, patients …

In this retrospective international multicenter study, we describe the clinical characteristics
and outcomes of patients with chronic lymphocytic leukemia (CLL) and related disorders …

Secondary immunodeficiency (SID) in patients with B-cell hematological malignancies is a
common condition that presents with recurrent infection. SID is due to both the inherent …

To better understand the relationship between baseline immunoglobulin measurements and
subsequent clinical outcomes in chronic lymphocytic leukemia (CLL), we performed a …